REPLY: Value Based Medicine Is Born, the Platform Created by Laife Reply for IEO That Makes Patient Care Increasingly Personalised and Appropriate

TURIN, Italy--(BUSINESS WIRE)--Laife Reply, a company within the Reply Group focused on using AI, Big Data and Machine Learning to innovate preventive healthcare and treatment processes has developed, in collaboration with IEO (European Institute of Oncology), the Value Based Medicine (VBM), a web platform to support the patient care cycle. The platform's objective is to use clinical information to predict, through statistical and artificial intelligence models, the outcomes of therapeutic and